Forty-one volunteers (male non-smokers) were exposed to formaldehyde (FA) vapours for 4 h/day over a period of five working days under strictly controlled conditions. For each exposure day, different exposure concentrations were used in a random order ranging from 0 up to 0.7 p.p.m. At concentrations of 0.3 and 0.4 p.p.m., four peaks of 0.6 or 0.8 p.p.m. for 15 min each were applied. During exposure, subjects had to perform bicycle exercises ($80 W) four times for 15 min. Blood samples, exfoliated nasal mucosa cells and nasal biopsies were taken before the first and after the last exposure. Nasal epithelial cells were additionally sampled 1, 2 and 3 weeks after the end of the exposure period. The alkaline comet assay, the sister chromatid exchange test and the cytokinesis-block micronucleus test were performed with blood samples. The micronucleus test was also performed with exfoliated nasal mucosa cells. The expression (mRNA level) of the glutathione (GSH)-dependent formaldehyde dehydrogenase (FDH, identical to alcohol dehydrogenase 5; ADH5; EC 1.2.1.46) was measured in blood samples by quantitative real-time reverse transcription-polymerase chain reaction with TaqMan probes. DNA microarray analyses using a full-genome human microarray were performed on blood samples and nasal biopsies of selected subgroups with the highest FA exposure at different days. Under the experimental conditions of this study, inhalation of FA did not lead to genotoxic effects in peripheral blood cells and nasal mucosa and had no effect on the expression of the FDH gene. Inhalation of FA did also not cause alterations in the expression of genes in a microarray analysis with nasal biopsies and peripheral blood cells.
Forty-one volunteers (male non-smokers) were exposed to formaldehyde (FA) vapours for 4 h/day over a period of five working days under strictly controlled conditions. For each exposure day, different exposure concentrations were used in a random order ranging from 0 up to 0.7 p.p.m. At concentrations of 0.3 and 0.4 p.p.m., four peaks of 0.6 or 0.8 p.p.m. for 15 min each were applied. During exposure, subjects had to perform bicycle exercises ($80 W) four times for 15 min. Blood samples, exfoliated nasal mucosa cells and nasal biopsies were taken before the first and after the last exposure. Nasal epithelial cells were additionally sampled 1, 2 and 3 weeks after the end of the exposure period. The alkaline comet assay, the sister chromatid exchange test and the cytokinesis-block micronucleus test were performed with blood samples. The micronucleus test was also performed with exfoliated nasal mucosa cells. The expression (mRNA level) of the glutathione (GSH)-dependent formaldehyde dehydrogenase (FDH, identical to alcohol dehydrogenase 5; ADH5; EC 1.2.1.46) was measured in blood samples by quantitative real-time reverse transcription-polymerase chain reaction with TaqMan probes. DNA microarray analyses using a full-genome human microarray were performed on blood samples and nasal biopsies of selected subgroups with the highest FA exposure at different days. Under the experimental conditions of this study, inhalation of FA did not lead to genotoxic effects in peripheral blood cells and nasal mucosa and had no effect on the expression of the FDH gene. Inhalation of FA did also not cause alterations in the expression of genes in a microarray analysis with nasal biopsies and peripheral blood cells.
Introduction
Many studies have shown that formaldehyde (FA) is genotoxic and mutagenic in vitro in various kinds of mammalian cells including cultured human blood and human nasal epithelial cells (1) (2) (3) (4) . FA induces DNA-protein crosslinks (DPX), sister chromatid exchanges (SCEs), micronuclei (MN), chromosome aberrations and, to a lesser extent, gene mutations (2, 3, 5, 6) . After inhalation, genotoxic effects (DPX and other DNA adducts) were induced in the nasal epithelium of experimental animals (7, 8) ; i.e. the site of first contact. However, distant site effects (e.g. in bone marrow and peripheral blood) were not found in appropriately performed animal studies (8) (9) (10) (11) . Although conflicting results were reported in human studies, several publications indicate increased genotoxic effects in exfoliated buccal and nasal cells as well as in peripheral blood of subjects exposed to FA at the workplace (1, (12) (13) (14) . Although concerns with regard to the plausibility and reliability of such studies have been expressed (2, 15) , the occurrence of genotoxic effects in humans exposed to FA is still a matter of concern.
We now had the chance to study genotoxic effects in a group of 41 volunteers exposed to FA by inhalation under strictly controlled conditions. The study was designed to investigate chemosensory effects and susceptibility of humans towards FA. The volunteers were exposed to FA over a period of five consecutive working days. Blood samples, exfoliated nasal mucosa cells and nasal biopsies were collected before the first and after the last exposure. DNA effects in the comet assay, the frequencies of SCEs and the frequencies of micronucleated cells in the cytokinesis-block micronucleus test (CBMNT) were measured in peripheral blood. MN were also scored in exfoliated nasal epithelial cells. Because recent studies investigated changes in gene expression as an indicator for FA exposure in vivo and in vitro (16) (17) (18) , we also performed microarray analyses in blood samples and nasal biopsies from volunteers before and after FA exposure.
Materials and methods
Subjects, FA exposure, blood samples, preparation of nasal mucosa cells and nasal biopsies All 41 subjects of this study were healthy male non-smokers or ex-smokers. Non-smoking status was confirmed by cotinine measurements in urine. A basic medical examination ascertained that the volunteers were in good health condition. Exclusion criteria were: severe allergy, manifest skin or airways disease, acute infection, insufficient visus without visual aid, .50 g alcohol per day, present use of psychotropic agents and exposure to ionising radiation or cytostatic drugs during the last 6 months. The subjects were informed about the nature of the study and potential adverse health effects and agreed to participate by signing the written informed consent. The protocol of the study was approved by the ethical commission of the Medical Faculty of the University of Heidelberg.
At five consecutive working days, volunteers were exposed in 12 groups of two to four persons in a chamber (4.3 Â 2.9 Â 2.4 m) according to the scheme shown in Table I and high-performance liquid chromatography analysis of samples drawn from the chamber air (DFG-DNPH-method). Each exposure lasted for 4 h. To simulate the situation of real workplaces (i.e. with periods of deep breathing due to physical activity), the subjects performed bicycle exercises ($80 W) four times for 15 min during the exposure period at predefined times. At days of peak exposures, two of these bicycle exercises were carried out at the time of an exposure peak.
Blood samples were obtained by venepuncture before the first exposure (Monday) and at the end of the last exposure (Friday). Heparinised blood samples for the genotoxicity tests were coded, stored on ice and immediately brought to the laboratory in Ulm where the tests were set up immediately (i.e. within 4 h after blood sampling). Blood for gene expression analysis and real-time reverse transcription-polymerase chain reaction (RT-PCR) was collected in PAX gene tubes, coded and carried to the laboratory in Ulm without cooling.
Nasal mucosa cells were collected with cotton buds from the inner turbinates. Samples were taken separately from the right and left nostril before the first exposure (Monday), after the last exposure (Friday) and 1, 2 and 3 weeks after the end of the exposure. Cotton buds were thoroughly rinsed in 0.9% NaCl, the cell suspension was centrifuged (10 min, 1000 r.p.m.) and cells were resuspended in 500 ll 0.9% NaCl. The cell suspension was placed on a pre-cleaned microscopic slide and dried on a heating plate. Two slides (right and left nostril) were prepared from each subject at all preparation times. Slides were coded and sent to the laboratory in Ulm where they were stained and evaluated.
Nasal biopsies were taken from the nostril with the larger inferior turbinate before the first exposure and after the last exposure (Friday, Day 5). After local anaesthesia with 4% Lidocainhydrochlorid up to three biopsies were taken from one nostril with cutting microforceps and immediately stored in liquid nitrogen. The biopsy samples were investigated from three subgroups of volunteers (A, B and C) who received the highest FA exposure (0.7 p.p.m.) at different days (see Microarray analysis of nasal biopsies and blood samples).
At the end of the study, all samples were carried on dry ice to the Microarray-Core Facility in Ulm where microarray analyses were performed.
Comet assay Aliquots of 5 ll heparinised whole blood were mixed with 120 ll low melting point agarose (0.5% in phosphate-buffered saline) and added to microscope slides (with frosted ends), which had been covered with a bottom layer of 1.5% agarose. Slides were lysed (pH 10; 4°C) and processed as described earlier (19) using a time of alkali denaturation of 25 min and electrophoresis (0.86 V/cm) of 25 min at a pH . 13. Images of 100 randomly selected cells stained with ethidium bromide were analysed (50 images from each of two coded slides) by image analysis (Comet Assay II; Perceptive Instruments). We evaluated the two image analysis parameters tail intensity (TI) and tail moment (TM). TM is calculated according to the formula: TM 5 (tail intensity/total comet intensity) Â (tail centre of gravity À peak position). The Wilcoxon signed rank test was used for the statistical analysis of the data.
SCE test
SCE tests were performed according to Schmid and Speit (2) with minor modifications. Whole blood (0.5 ml) was cultured for 64 h in RPMI medium supplemented with 1% phytohaemagglutinin-L (PHA-L) and 10 lg/ml 5-bromodeoxyuridine. Colcemid (5 Â 10 À7 M) was added for the final 2 h. Chromosome preparation was done following standard procedures. Cells were centrifuged, resuspended in a hypotonic solution (0.4% KCl) for 20 min and fixed three times in methanol:glacial acetic acid (3 þ 1). For sister chromatid differentiation, air-dried slides were covered with Soerensen buffer (pH 6.8) and irradiated with an 8-W UV lamp (254 nm) at a distance of 10 cm for 20 min. Subsequently, slides were incubated in 1Â SSC for 20 min at 60°C and then stained with 7% Giemsa in Soerensen buffer. SCE were scored in 30 cells per sample. Toxicity was measured by scoring first division mitoses (M1), second division mitoses (M2) and third division mitoses (M3) among 100 metaphases and calculating the proliferation index (PI) according to the formula:
. The Wilcoxon signed rank test was used for the statistical analysis of the data.
Micronucleus test (CBMNT) with peripheral blood
The CBMNT was performed as described earlier (2) with minor modifications. Blood (0.5 ml) was added to 4.5 ml of RPMI medium, supplemented with 1% PHA-L and incubated at 37°C. Cytochalasin B (CytB) was added to the cultures at a final concentration of 3 lg/ml 44 h after PHA stimulation. Cultures were harvested 24 h later, giving a total culture time of 68 h. Cells were harvested by centrifugation, treated with a hypotonic solution (0.56% KCl) and fixed once with methanol:glacial acetic acid (5 þ 1) mixed with an equal amount of 0.9% NaCl and then fixed three times with methanol:glacial acetic acid. Air-dried slides were stained with acridine orange (60 lg/ml in phosphate buffer). MN were scored in 1000 binucleated cells and the frequency of cells with MN was determined. Toxicity was measured using the nuclear division index (NDI) which was calculated from 500 cells according to the formula: After RT at 50°C for 20 min and an initial activation step at 95°C for 15 min, 45 cycles of 94°C for 45 s and 60°C for 45 s were followed (ABI 7900HT Fast Real-Time PCR System; Applied Biosystems). Per blood sample, two RNA preparations were investigated independently and each RNA was analysed in triplicate. In each PCR analysis, a negative control containing water instead of RNA was included. Data were analysed using the ABI Sequence Detection System version 2.3 software. Quantification of the FDH expression was performed via DCt value determination, which represents the difference in threshold cycles between the target and the reference gene. The lower the DCt value, the higher is the FDH expression. Threshold cycles (crossing points) are the cycles at which the amplification plot crosses the threshold. This was determined by the analysis software for all samples. The threshold was set above the background and significantly below the plateau of the amplification plot, i.e. in the linear region.
Microarray analysis of nasal biopsies and blood samples
Microarray analyses were performed with three different subgroups which were exposed to the highest FA concentration at different days:
Subgroup A (n 5 6) was exposed to the highest FA concentration on Tuesday (Day 2; Groups 3 and 12 from Table I ).
Subgroup B (n 5 7) was exposed to the highest FA concentration on Thursday (Day 4; Groups 8 and 11 from Table I ).
Subgroup C (n 5 8) was exposed to the highest FA concentration on Friday (Day 5; Groups 1 and 9 from Table I ). No sufficient amount of RNA was isolated from the nasal biopsie of one subject of the Subgroup A. Therefore, nasal biopsies from only five subjects were investigated with the highest exposure on Tuesday. RNA was isolated using the RNeasy Mini Kit (Qiagen) including the mRNase-free DNase set for the nasal biopsies and the PAXGene RNA Kit for the blood samples. Two micrograms of total RNA were used as starting material and 15 lg cRNA were used per hybridisation (GeneChip Fluidics Station 450; Affymetrix, Santa Clara, CA). The total RNAs were amplified and labelled following the one-cycle target labelling protocol (http://www.affymetrix.com/). The labelled cRNAs were hybridised to U133Plus 2.0 Affymetrix GeneChip arrays (Affymetrix). The chips were scanned with an Affymetrix GeneChip Scanner 3000 and subsequent images analysed using GCOS 1.4 (Affymetrix). RNA integrity was checked by gel electrophoresis and 3#/5# expression ratios of GAPDH as measured by the Affymetrix U133 Plus 2.0 array. The gene expression omnibus accession number for these microarray studies is GSE27263.
Transcriptome analyses were performed using BRB-ArrayTools developed by Dr Richard Simon and BRB-ArrayTools Development Team (http:// linus.nci.nih.gov/BRB-ArrayTools.html). Raw feature data were normalised and log 2 intensity expression summary values for each probe set were calculated using robust multi-array average (21) .
In addition to this in vivo study, in vitro experiments with human blood samples were performed. Blood samples from five volunteers were exposed in vitro for 4 h to 50, 100 or 200 lM FA. This protocol was chosen because experiments with human nasal epithelial cells (HNECs) had shown that the strongest effect on gene expression was measured after 4 h FA exposure (18) . For microarray analysis, RNA was isolated with the QIAamp RNA Blood Mini Kit (Qiagen) and DNA was completely removed by using the mRNasefree DNase set of the same supplier. Two micrograms of total RNA was processed for each sample as described above.
We identified genes that were differentially expressed in blood and nasal biopsies after FA exposure in vivo in comparison with the samples before exposure using a paired two-sample t-test. The differentially expressed genes in blood exposed to FA in vitro were analysed unpaired. Genes were considered statistically significant if their P-value was ,0.05 and the change in expression was !2-fold. In addition, genes with !1.5-fold change in expression are also shown to include more subtle changes in gene expression.
Results
Table II summarises the results of the genotoxicity tests performed before and after exposure. The comet assay was successfully performed with blood from 37 subjects. Four subjects could not be tested because of a technical problem with the electrophoresis box. No statistically significant difference was measured for the TM in the comet assay, whereas there was a small but statistically significant increase in TI after exposure (2.66 versus 2.28). The SCE test and the CBMNT were successfully performed with blood samples from 40 subjects. Lymphocytes did not proliferate in all blood cultures of one volunteer. The mean SCE frequencies before and after exposure were the same and the proliferation index did not indicate any toxic effect. The frequency of cells with MN was slightly lower after exposure and the NDI was unchanged. Table III summarises the results of the micronucleus test (MNT) with nasal epithelial cells. Two slides were prepared from each subject at the five sampling times. However, it was not possible to analyse some of the slides because of the É poor quality of slides, contamination with bacteria or with blood. In several cases, only one of the two slides (1000 cells) could be evaluated. Because all slides were individually coded, it was not possible to identify the two parallel slides and to increase the number of scored cells for the slide with sufficient quality. Between 56 000 and 62 000 cells were analysed per data point. The results shown in Table III 
Microarray analyses only revealed minor changes in gene expression in nasal biopsies before and after FA exposure (Table IV ). The number of altered genes with at least 2-fold changes was between 2 and 17. The individual genes are listed in Table V . There was no relationship between the number of altered genes and the time since the highest exposure (0.7 p.p.m.). As expected, more genes were altered in expression when changes of at least 1.5-fold were considered and the pattern of altered genes was similar. However, at this level of changed expression, a higher false-positive rate might be present and, therefore, evaluation at the 2-fold level is more reliable.
This study did not include a group which had no exposure to FA throughout the week and which could serve as a negative control for the microarray analyses (i.e. indicating the background frequency of changed genes without FA exposure but with all other manipulations and examinations during the week). Therefore, we determined background frequencies of changed genes in our study by analysing the three subgroups against each other before exposure (Monday samples). The comparisons between two of the subgroups revealed that in nasal cells up to 64 genes can be changed !2-fold in the absence of exposure (33 genes between Subgroup A and Subgroup B, 6 between Subgroup B and Subgroup C and 64 between Subgroup B and Subgroup C).
Table VI summarises the results for the blood samples of the 21 volunteers (Subgroups A, B and C) investigated by microarray analysis. Considering changes of at least 2-fold, the highest number of genes with altered expression (n 5 9) was measured in the Subgroup B (highest exposure on Thursday). In this group, only two genes were changed in nasal biopsies, which was the lowest effect among the three groups. 
Genotoxicity of FA
A complete list of the genes with changes in expression of the blood samples is shown in Table VII . When considering 1.5-fold changes, the number of genes is clearly increased in the Subgroups A and B but not in Subgroup C. To determine background effects in changes of gene expression, we comparatively analysed the three subgroups before exposure (Monday samples). In the absence of exposure, 19 genes were changed (at least 2-fold) when comparing Subgroup A and Subgroup B, 9 genes were changed (at least 2-fold) when comparing Subgroup B and Subgroup C and 2 genes were changed (at least 2-fold) when comparing Subgroup A and Subgroup C. This analysis shows that the effects after exposure were in the same range as the background level of changes in the absence of exposure.
To enable a direct comparison between the gene expression data of this study with our previous results with HNEC exposed to FA in vitro, we did not correct our data by means of a 'false discovery rate'. However, if considering a false discovery rate of 10%, no genes at all would reveal a change in expression in our nasal biopsies and blood samples from exposed subjects. Table VIII shows the results of the additionally performed experiments with blood exposed in vitro for 4 h. This protocol was chosen because experiments with HNECs have shown that the strongest effect on gene expression was measured after 4 h FA exposure (18) . The results for blood directly exposed in vitro clearly indicate that a high FA concentration (200 lM) is necessary to induce significant effects. While there was no effect on gene expression after treatment with 50 or 100 lM FA, 342 genes (295 after correcting for a false discovery rate below 10%) were differentially regulated (!2-fold) after treatment with 200 lM. Under these conditions, the majority of genes was downregulated and only few genes (n 5 18) were up-regulated at least 2-fold. None of these genes was changed in the blood of volunteers exposed to FA by inhalation.
Discussion
Our results clearly indicate that under the conditions of this study exposure to FA by inhalation does not induce genotoxic effects in peripheral blood. The comet assay, the SCE test and the CBMNT revealed negative results. The comet assay detects primary DNA damage present in leukocytes at the time of blood sampling. In our study, the TI (amount of DNA in the tail) was slightly increased and the difference was statistically significant, whereas no statistically significant difference was measured by the TM. It is still a matter of debate whether the 'tail intensity' or the 'tail moment' is the most appropriate parameter for the presentation of comet assay results (22) . However, this discussion is related to differences in the intelligibility and not to differences in the sensitivity of the twoparameters. In fact, in vitro studies with various cultured mammalian cells (including human blood cells) clearly indicated that genotoxic effects of FA are detected by both comet assay parameters with the same sensitivity (2-4). Furthermore, numerous experimental studies have demonstrated that exposure of cells to FA leads to reduced and not to increased DNA migration (2) (3) (4) 23) . This effect is explained by the fact that FA mainly induces DNA-protein cross links (DPX) and FA-induced DPX most efficiently reduce DNA migration in the comet assay (3, 23) . Therefore, the increase in tail intensity can be explained by assay variability and does not have biological relevance. SCE and MN arise in cultured human lymphocytes as a consequence of persistent DNA alterations. Increased frequencies of SCE and MN are measured when lymphocytes carry sufficient amounts of DNA damage at the time of blood sampling that lead to impaired replication or misrepair in proliferating lymphocytes in vitro. Considering what is generally known about the toxicokinetics of FA and the biology of the genotoxicity tests, it is highly unlikely that lymphocytes are significantly exposed in vivo and have sufficient levels of damage to produce SCE and MN in vitro (2, 24, 25) . Our study shows that exposure to FA by inhalation for 5 days with concentrations up to 0.7 p.p.m. or peaks of 0.8 p.p.m. does not lead to enhanced formation of SCE and MN in cultured lymphocytes. Because DPX are constantly removed from lymphocytes (26), they should not accumulate during longer exposure times (e.g. at the workplace). Previously published studies showed conflicting results (1) but some reported positive results with the SCE test and the CBMNT for workers exposed to FA (1, (12) (13) (14) . Under the assumption that FA is not systemically available, genotoxic effects induced by FA in lymphocytes in vivo appear to be implausible. Therefore, further attempts are necessary for a better understanding and correct assessment of human biomonitoring studies with cytogenetic markers and their relevance for hazard identification and risk estimation.
The MNT with exfoliated epithelial buccal and nasal cells is less standardised than the CBMNT but was repeatedly used for investigating humans exposed to FA. The limitations of this approach have been critically commented (15) . We have recently published results for 21 human volunteers exposed to FA vapours (up to 0.5 p.p.m. with peaks of 1.0 p.p.m.) for 4 h/ day over a period of 10 working days under similar conditions as in the present study. We performed the MNT with buccal smears and did not measure increased frequencies of MN (20) . Because inhalation of FA may lead to a higher exposure of the nasal epithelium during breathing than of the buccal epithelium and the nasal mucosa has fewer cell layers than the buccal mucosa, the MNT with nasal cells should be more sensitive than the MNT with buccal cells. Therefore, we tried to investigate nasal epithelial cells in this study. However, despite the fact that the method was well established in our laboratory and the people involved in cell sampling were well trained, we faced some problems with the quality of several slides and 14% of the data are missing. In our experience, the differences in quality were mainly due to differences in the state of the nasal mucosa of the volunteers investigated. Another problem is the low but variable background in cells with MN. In many slides (237 of 293), no MN was detected among 1000 cells. This finding is in agreement with a published study with styreneexposed workers (27), which also reported a very similar background value (0.23). Baseline MN frequencies in nasal cells of controls used in FA studies varied between 0.25 and 2.0 (28, 29) . There are only two publications (based on one study) that reported results for both, nasal and buccal cells after FA exposure (29, 30) . Interestingly, a significant effect was reported for buccal cells but not for nasal cells. Our study with nasal cells which is based on the evaluation of $60 000 cells per data point did not indicate increased MN frequencies after FA exposure and supports our negative findings with buccal cells under similar conditions (20) . However, this result should be interpreted with great care because of the above-mentioned limitations of this approach. As already stated earlier (15) , there is need for standardisation and validation of the MNT with exfoliated cells to make this assay a reliable one. With regard to the buccal MNT, such activities started recently (31). The glutathione-dependent FDH (identical to ADH5) is the most important enzyme for the metabolic inactivation of FA. Using real-time RT-PCR with TaqMan probes, we measured the expression of this gene (mRNA levels) in blood samples obtained from the volunteers before and after FA exposure. FA exposure under the conditions of this study did not have a significant effect on the expression of FDH. Up to now, there is no evidence for an FA-dependent regulation of FDH. In in vitro experiments with A549 cells (a human lung cell line) expression of FDH was not induced after treatment of cells with FA (50-300 lM) for 1, 4 or 24 h (32). FDH was also not differentially regulated in cultured HNECs exposed to FA under various conditions (18) .
Microarray analyses in nasal biopsies and blood samples only revealed minor effects for genes with altered expression after exposure to FA by inhalation in a subgroup of volunteers. The selection of the volunteers was based on our experience with HNEC exposed to FA in vitro. These results suggested that after acute exposure, the largest amount of genes was altered in expression a few hours after exposure (18) . Therefore, we investigated all volunteers who were exposed to 0.7 p.p.m. FA on Friday (i.e. immediately before taking the biopsies; Subgroup C) and all volunteers exposed to FA on Thursday (i.e. 24 h before taking the biopsies; Subgroup B). Furthermore, volunteers exposed to 0.7 p.p.m. on Tuesday and the last FA exposure on Thursday (Subgroup A; 0 p.p.m. exposure on Friday) were comparatively investigated to identify a possible effect of the exposure schedule on changes in gene expression. The results clearly indicate that there was no exposure-related effect in nasal mucosa cells or in blood. Considering the differences in gene expression between samples from the subgroups before exposure, one can conclude that the changes measured after exposure in our study mainly reflect assay variability and are not related to FA exposure. We analysed the data at two different levels of changed expression (i.e. $1.5-fold and 2-fold). As expected, more genes were altered in expression when changes of $1.5-fold were considered. Interestingly, the pattern of the magnitude of altered genes was similar. Because a higher false-positive rate has to be expected at the level of 1.5-fold changes, evaluation at the 2-fold level is more reliable. To enable a direct comparison between the gene expression data of this study with our previous results with HNEC exposed to FA in vitro, we did not correct our data by means of a false discovery rate. However, if considering a false discovery rate of 10%, no genes at all would reveal a change in expression in our nasal biopsies and blood samples from exposed subjects.
Only very few genes were identified among the altered genes with corresponding effects at different times or in different tissues. In nasal biopsies, only 'LACRT' was down-regulated in Subgroup A and Subgroup C (but not in Subgroup B). A comparison between nasal biopsies and blood samples revealed only one gene (PDK4) which was up-regulated in Subgroup B in nasal biopsies and in blood samples of Subgroup A and Subgroup B. These two genes are not related to FA metabolism, FA toxicity or any other response to a toxic insult. These isolated corresponding changes do not indicate an FA-related effect. All other genes were only changed in nasal or blood cells and only in one of the three subgroups investigated.
Altogether, our results suggest that FA exposure by inhalation for 5 days (4 h/day) with concentrations up to 0.7 p.p.m. (or peak exposures of 0.8 p.p.m.) does not lead to biologically significant changes in the expression of genes in the nasal epithelium and in peripheral blood. Our results are in good agreement with results of an inhalation study performed with rats (17) . After exposure of rats to 0.7 p.p.m. FA for 5 days, no significantly altered genes were found in nasal epithelial tissues. At 2 p.p.m., only 15 genes were altered 1.5-fold or higher at Day 5, which is a rather marginal effect. No genes were changed in expression after exposure to 2 p.p.m. for 6 or 15 days.
In contrast to our negative results with peripheral blood of subjects exposed to FA, one previously published study reported elevated expression of six genes in peripheral blood of subjects exposed to FA in new buildings (16) . These genes were not differentially regulated in nasal biopsies and peripheral blood of subjects exposed to FA in our study and did not show altered expression in human blood exposed to FA in vitro. Only one of these genes (cyclinL1; involved in transcription) was changed (but down-regulated) in HNEC treated with 200 lM FA for 4 h (18). Our additionally performed experiments with blood exposed in vitro for 4 h are important because they indicate that a high FA concentration (200 lM) at the target cell is necessary to induce significant effects on gene expression. It is highly unlikely that such high FA concentrations are reached in cells of humans after environmental exposure to FA. In the light of our new findings, it seems to be unlikely that the effects reported by Li et al. are indicators for a systemic toxic effect of FA, they might rather represent secondary effects or a chance finding. The genes with increased expression after FA exposure were not confirmed in any of our analyses. Therefore, we conclude that up to now, no differentially regulated genes have been unequivocally identified which could serve as a general marker for FA exposure.
In summary, our study shows that exposure to FA by inhalation does not lead to genotoxic effects and biologically relevant changes in gene expression in the nose and the blood of healthy volunteers exposed under strictly controlled conditions for 4 h/day over a period of five working days with constant concentrations up to 0. 
